← Leaderboards
Maryann L Haldi
Phylonix Pharmaceuticals, Inc.
$2,524,006
Attributed
$2,524,006
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $926.3K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$2,524,006 · 7
By mechanism
R44$1,676,163 · 2
R43$847,843 · 5
Top collaborators
No co-investigators on record.
Most similar at Phylonix Pharmaceuticals, Inc.
Same institution · by research overlap
- Chuenlei Parng$2,901,526
- Wen L Seng$5,142,092
- Christopher Ton$169,605
Others in their field
Top investigators on “Zebrafish”
- Leonard I Zon · Children'S Hospital Boston$58,820,730
- Monte Westerfield · University Of Oregon$50,217,878
- Richard A Gibbs · Baylor College Of Medicine$49,965,365
- Karl Alexander Deisseroth · Stanford University$29,745,200
- William S Talbot · Stanford University$29,496,829
- Robert L Tanguay · Oregon State University$27,361,484
Research focus
ZebrafishApoptosisIn VivoPharmaceutical PreparationsAnimal ModelScreening ProcedureMammalsMovementPharmacologic SubstancePersonsLeadEvaluationGovernmentInstrumentationStaining MethodScanningSlideStainsImageBiological ProductsCell MotilityBiological FactorsLibrariesRecovery Of Function
Grant awards (11)
In Vivo Screen for Neuroprotective Agents$297,558
R44 · FY2009 · NS · contact PI
In Vivo Screen for Neuroprotective Agents$75,518
R44 · FY2009 · NS · contact PI
In Vivo Screen for Neuroprotective Agents$343,879
R44 · FY2008 · NS · contact PI
Zebrafish Screen for Ototoxic and Otoprotective Agents$194,683
R44 · FY2008 · DC · contact PI
Zebrafish Screen for Ototoxic and Otoprotective Agents$406,935
R44 · FY2007 · DC · contact PI
In Vivo Screen for Neuroprotective Agents$357,590
R44 · FY2007 · NS · contact PI
Zebrafish Muscular Dystrophy Model for Drug Screening$161,810
R43 · FY2007 · AR · contact PI
Brain Cancer Zebrafish Xenotransplant Model for Drug Screening$168,689
R43 · FY2006 · NS · contact PI
Zebrafish Xenotransplant Model for Colorectal Cancer$164,366
R43 · FY2005 · DK
In Vivo Ocular Angiogenesis Assay$156,599
R43 · FY2005 · EY
New Model for Eye Disease$196,379
R43 · FY2004 · EY